Skip to main content
. 2019 Mar 26;9:5167. doi: 10.1038/s41598-019-41610-6

Table 3.

Change of expression of solute carrier family 2 (SLC2A) genes in oocytes following FSK and IBMX treatment.

FeatureID Annotations –database object name Experiment –fold change* (original values) Kal’s Z-test: P-value correction Number of mapped reads before FSK and IBMX treatment Number of mapped reads after FSK and IBMX treatment Change of gene expression
SLC2A3 Solute carrier family 2, facilitated glucose transporter member 3 14.822526 0 293 4343 upregulated
SLC2A12 Solute carrier family 2, facilitated glucose transporter member 12 11 0.022863918 1 11 upregulated
SLC2A10 Solute carrier family 2, facilitated glucose transporter member 10 9.5 0.001772048 2 19 upregulated
SLC2A1 Solute carrier family 2, facilitated glucose transporter member 1 4.3222222 0 270 1167 upregulated
SLC2A5 Solute carrier family 2, facilitated glucose transporter member 5 2 1 1 2 unchanged
SLC2A4 Solute carrier family 2, facilitated glucose transporter member 4 1.5 1 2 3 unchanged
SLC2A13 Solute carrier family 2, facilitated glucose transporter member 13 1.5 0.714956314 10 15 unchanged
SLC2A8 Solute carrier family 2, facilitated glucose transporter member 8 1.0643029 0.587908435 1664 1771 unchanged
SLC2A2 Solute carrier family 2, facilitated glucose transporter member 2 −1 1 1 1 unchanged

*When the ratio is less than 1, it is converted to its negative inverse.

The transcriptome data have been deposited in the DDBJ Sequence Read Archive (DRA) with accession number DRA006403.

Bold show upregulated.